The GCH1 Gene DYT5A Genetic Test is a specialized diagnostic tool designed to identify mutations in the GCH1 gene, which are associated with DYT5A, also known as Segawa syndrome or dopa-responsive dystonia. This condition is a rare, inherited disorder characterized by dystonia, tremors, and issues with gait that typically responds well to treatment with levodopa, a medication commonly used to treat Parkinson's disease. The test involves analyzing the patient's DNA to detect any genetic variations in the GCH1 gene that may lead to the development of DYT5A.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information for the accurate diagnosis and management of individuals suspected to have dopa-responsive dystonia. With a cost of 4400 AED, the test is an investment in gaining a comprehensive understanding of the genetic underpinnings of the condition, which can significantly impact treatment decisions and outcomes. DNA Labs UAE employs cutting-edge technology and expertise to ensure reliable and accurate test results, making it a trusted choice for patients and healthcare providers seeking genetic testing services.
The THAP1 Gene DYT6 Genetic Test is a specialized diagnostic tool designed to identify mutations in the THAP1 gene, which are associated with DYT6 dystonia. DYT6 dystonia is a type of dystonia, a movement disorder that causes involuntary muscle contractions, leading to repetitive movements or abnormal postures. This particular form of dystonia is often hereditary and can affect various parts of the body, including the limbs, neck, and face.
The test is particularly valuable for individuals who have a family history of DYT6 dystonia or who exhibit symptoms suggestive of the condition. Early and accurate diagnosis through the THAP1 Gene DYT6 Genetic Test can significantly aid in the management and treatment of the disorder, potentially improving the quality of life for those affected.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing a sample of the patient's DNA to look for specific mutations in the THAP1 gene. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic diagnostics, ensuring high accuracy and reliability of test results.
The cost of the THAP1 Gene DYT6 Genetic Test at DNA Labs UAE is 4400 AED. While the cost may seem significant, the investment in such a diagnostic test can be invaluable for those affected by DYT6 dystonia, offering insights into treatment options and helping to manage the disorder more effectively.
The SLC2A1 gene, also known as the solute carrier family 2 member 1 gene, plays a crucial role in the human body by facilitating the transport of glucose across the blood-brain barrier. Mutations in the SLC2A1 gene are associated with various neurological disorders, including DYT8, also known as Paroxysmal Exercise-Induced Dyskinesia (PED). This condition is characterized by abnormal, involuntary movements triggered by physical exertion or prolonged exercise.
The DYT8 genetic test specifically looks for mutations in the SLC2A1 gene to confirm a diagnosis of PED. This test is crucial for individuals exhibiting symptoms of DYT8, as it helps in the accurate diagnosis and management of the condition. Early detection through genetic testing can lead to better management of symptoms and improve the quality of life for those affected.
In the United Arab Emirates, DNA Labs UAE offers the SLC2A1 gene DYT8 genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals experienced in genetic diagnostics. They ensure that the testing process is efficient and results are accurate and reliable, providing crucial information for patients and their families dealing with DYT8.
The ARX gene test for Early Infantile Epileptic Encephalopathy Type 1 (EIEE1) is a specialized genetic examination aimed at detecting mutations in the ARX gene, which are known to cause this severe neurological condition. EIEE1 is characterized by frequent seizures that begin within the first few months of life, accompanied by significant developmental delays and intellectual disability. The condition is part of a group of disorders known as ARX-related epilepsies, which are attributed to various mutations within the ARX gene.
DNA Labs UAE offers this critical diagnostic test for families and individuals at risk of or showing symptoms of EIEE1. By employing advanced genetic sequencing techniques, the test scrutinizes the ARX gene for specific mutations that confirm the diagnosis of EIEE1, thereby enabling early intervention, management strategies, and personalized care plans for affected individuals. The cost of the test is set at 4400 AED, reflecting the specialized nature of the examination and the sophisticated technology employed.
Early diagnosis through the ARX gene test can significantly impact the management of the condition, offering insights into potential treatments and therapies that may improve the quality of life for those affected. DNA Labs UAE provides this test with the utmost care and confidentiality, ensuring that patients and their families receive comprehensive support throughout the diagnostic process.
The PNKP gene plays a crucial role in DNA repair and maintenance, and mutations in this gene are associated with early infantile epileptic encephalopathy type 10 (EIEE10), a severe neurological disorder. This condition is characterized by frequent seizures that begin in infancy, developmental delays, and other potential neurological complications. Identifying mutations in the PNKP gene is essential for diagnosing EIEE10, guiding treatment options, and providing information on the prognosis.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the PNKP gene. The test is a vital tool for healthcare professionals and families seeking answers for infants showing symptoms consistent with EIEE10. By providing a definitive diagnosis, this test can help in the management and treatment planning for affected individuals.
The cost of the PNKP gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, typically through a blood draw or cheek swab, and comprehensive analysis to identify any mutations in the PNKP gene. Results from this test can offer invaluable insights for affected families and contribute to a better understanding of the condition, potentially leading to more effective management and care strategies for those diagnosed with early infantile epileptic encephalopathy type 10.
The SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test is a specialized diagnostic tool used to identify mutations in the SCN2A gene, which are linked to Early Infantile Epileptic Encephalopathy Type 11 (EIEE11). This condition is a severe form of epilepsy that begins in infancy and is characterized by frequent seizures and significant developmental delays. The test is crucial for early diagnosis and management of the condition, allowing healthcare providers to tailor treatment plans to the individual needs of the patient.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the SCN2A gene. The accuracy and reliability of the test make it a valuable resource for families seeking answers to complex neurological conditions.
The cost of the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test is 4400 AED. While the price may seem significant, the insights provided by the test can be invaluable in guiding the clinical management of affected individuals, potentially improving outcomes and quality of life.
The PLCB1 gene plays a crucial role in brain development and function. Mutations in this gene have been linked to early infantile epileptic encephalopathy type 12 (EIEE12), a severe neurological disorder. This condition is characterized by early-onset seizures, developmental delay, and sometimes other neurological complications. Genetic testing for mutations in the PLCB1 gene is essential for diagnosing EIEE12, guiding treatment options, and providing genetic counseling for affected families.
At DNA Labs UAE, a specialized genetic test is available for identifying mutations in the PLCB1 gene associated with early infantile epileptic encephalopathy type 12. The test involves analyzing the patient's DNA to detect specific genetic alterations that cause the condition. This precise genetic testing is a crucial step in the diagnosis and management of EIEE12, allowing for tailored treatment plans and support for patients and their families.
The cost of the PLCB1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to identify the genetic underpinnings of EIEE12, providing invaluable information for affected individuals and their healthcare providers. Through this testing, DNA Labs UAE offers hope and direction for families navigating the challenges of early infantile epileptic encephalopathy type 12.
The SCN8A gene early infantile epileptic encephalopathy type 13 genetic test is a specialized diagnostic tool aimed at identifying mutations in the SCN8A gene, which have been linked to a severe form of epilepsy known as early infantile epileptic encephalopathy type 13 (EIEE13). This condition is characterized by frequent seizures that begin in the first months of life, often accompanied by developmental delays and other neurological issues. The SCN8A gene plays a crucial role in the functioning of brain cells, and mutations in this gene can disrupt the normal electrical activity in the brain, leading to epilepsy.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the specialized nature of the analysis and the sophisticated technology employed to accurately detect mutations in the SCN8A gene. By identifying these genetic mutations, the test can provide crucial information for the diagnosis and management of early infantile epileptic encephalopathy type 13, enabling healthcare providers to tailor treatment plans to the specific needs of their patients. This can include targeted therapies that may be more effective based on the patient's genetic makeup, thereby improving outcomes and enhancing the quality of life for those affected by this challenging condition.
The KCNT1 gene is associated with early infantile epileptic encephalopathy type 14 (EIEE14), a severe form of epilepsy that begins in infancy. This condition is characterized by frequent seizures and significant developmental delays, impacting an individual's quality of life. The KCNT1 gene plays a crucial role in the proper functioning of neurons, and mutations in this gene disrupt the normal electrical activity in the brain, leading to epilepsy.
Genetic testing for mutations in the KCNT1 gene is essential for the accurate diagnosis and management of EIEE14. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the KCNT1 gene. The test is a valuable tool for families seeking answers to their child’s severe epilepsy, providing crucial information that can guide treatment decisions and genetic counseling.
The cost of the KCNT1 gene test at DNA Labs UAE is 4400 AED. This investment can be invaluable for affected families, as it not only helps in confirming the diagnosis but also assists in understanding the risk of passing the condition to future generations. Additionally, knowing the specific genetic mutation can open up opportunities for targeted therapies and interventions, potentially improving the quality of life for those affected by EIEE14.
The ST3GAL3 gene is associated with early infantile epileptic encephalopathy type 15 (EIEE15), a rare and severe neurological disorder. This condition is characterized by frequent seizures that begin in infancy, developmental delay, and other possible neurological impairments. The ST3GAL3 gene plays a crucial role in brain development and function, and mutations in this gene are responsible for the disorder.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the ST3GAL3 gene, aiding in the diagnosis of early infantile epileptic encephalopathy type 15. The test is a vital tool for families seeking answers to developmental and epileptic concerns in infants, providing them with crucial information for medical management and treatment planning.
The cost of the ST3GAL3 gene test at DNA Labs UAE is 4400 AED. This investment allows for a comprehensive analysis of the gene in question, offering insights that can significantly impact the clinical approach to managing and supporting affected individuals. Early diagnosis through this genetic testing can facilitate timely interventions, potentially improving outcomes and quality of life for those diagnosed with EIEE15.
